Paclitaxel Protein-Bound Injection Shortage
Last Updated: September 4, 2022
Status: Current
Reason for the Shortage
-
- Apotex has paclitaxel protein-bound available.
- TWi Pharmaceuticals has paclitaxel protein-bound available.
- Bristol-Myers Squibb had Abraxane on shortage due to manufacturing delays.
Available Products
-
- Abraxane intravenous lyophilized powder for injection, Bristol-Myers Squibb, 100 mg, vial, NDC 68817-0134-50
- Paclitaxel protein-bound intravenous lyophilized powder for injection, Apotex, 100 mg, vial, NDC 60505-6230-04
- Paclitaxel protein-bound intravenous lyophilized powder for injection, TWi Pharmaceuticals, 100 mg, vial, NDC 24979-0710-51
Estimated Resupply Dates
-
- All marketed presentations are available.
Updated
Updated September 4, 2022 by Elyse MacDonald, PharmD, MS, BCPS. Created September 16, 2021 by Stephen Andrews, PharmD, BCPS, CPPS, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.